课题基金 / 基金详情

Dissecting the origins and microenvironment of replication repair deficient hypermutant gliomas for novel immune based therapies

Dissecting the origins and microenvironment of replication repair deficient hypermutant gliomas for novel immune based therapies
剖析复制修复缺陷型超突变神经胶质瘤的起源和微环境，用于新型免疫疗法
批准号：
444717
负责人：
Tabori Uri
金额：
$94.74万
依托单位：
Hospital for Sick Children (Toronto)
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2021
资助国家：
加拿大
项目状态：
未结题
起止时间：
2021-04-01 至 2026-04-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=444717&lang=en
关键词：
Brain Tumours Cancer Genetics Gliomas Hypermutation Immunotherapy

项目摘要

项目成果

Tabori Uri的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Gliomas are the most common brain tumours in children, adolescents, and young adults (CAYA, 0-40 years) and are a leading cause of cancer death in this population. We discovered that some of these gliomas contain the highest number of DNA mutations (hyper
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Uncovering the mechanism and impact of novel genetic and epigenetic promoter alterations on tissue-specific mismatch repair deficient cancers
Biological and translational implications of replication repair deficiency and hypermutation in human cancer
Translating genomic discoveries to cure ultrahypermutant mismatch repair deficient brain tumors
Novel implications of THOR hypermethylation in telomere maintenance and gliomageneis.
海外基金